Tectonic Therapeutic, Inc. financial data

Symbol
TECX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
490 Arsenal Way, Suite 210, Watertown, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
AvroBio, Inc. (to 6/18/2024), AVROBIO, Inc. (to 6/18/2024)
Latest financial report
10-K - Q4 2024 - Mar 20, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.01K % +117%
Debt-to-equity 17.2 %
Return On Equity -64.8 % -211%
Return On Assets -38.2 % +18.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 18.7M shares -58.4%
Common Stock, Shares, Outstanding 14.9M shares +955%
Entity Public Float 115M USD +214%
Common Stock, Value, Issued 2K USD
Weighted Average Number of Shares Outstanding, Basic 8.49M shares +569%
Weighted Average Number of Shares Outstanding, Diluted 8.49M shares +569%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 41.4M USD +11.9%
General and Administrative Expense 16.7M USD +117%
Costs and Expenses 3.24M USD -3.31%
Operating Income (Loss) -58M USD -29.9%
Nonoperating Income (Expense) 33K USD -98.2%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -58M USD -35.4%
Earnings Per Share, Basic -6.83 USD/shares +79.8%
Earnings Per Share, Diluted -6.83 USD/shares +79.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 141M USD +391%
Other Assets, Current 626K USD -25.9%
Assets, Current 147M USD +376%
Property, Plant and Equipment, Net 2.15M USD -31.1%
Operating Lease, Right-of-Use Asset 2.24M USD -16.3%
Other Assets, Noncurrent 156K USD +403%
Assets 153M USD +288%
Accounts Payable, Current 976K USD +139%
Employee-related Liabilities, Current 3.11M USD +29.3%
Accrued Liabilities, Current 7.85M USD -3.57%
Liabilities, Current 11.6M USD -71.6%
Deferred Income Tax Liabilities, Net 0 USD
Operating Lease, Liability, Noncurrent 132K USD -92%
Liabilities 12.1M USD -72.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 9K USD
Retained Earnings (Accumulated Deficit) -149M USD -64%
Stockholders' Equity Attributable to Parent 141M USD
Liabilities and Equity 153M USD +288%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -7.57M USD +62.7%
Net Cash Provided by (Used in) Financing Activities 30M USD
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 14.9M shares +955%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7.54M USD +62.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 142M USD +383%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 170M USD +463%
Deferred Tax Assets, Gross 171M USD +432%
Operating Lease, Liability 2.43M USD +176%
Depreciation 281K USD +10.2%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 2.53M USD
Property, Plant and Equipment, Gross 4.9M USD -1.65%
Operating Lease, Liability, Current 2.3M USD +70.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 132K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 2.4M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 101K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 0 USD
Deferred Tax Assets, Operating Loss Carryforwards 109M USD +860%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares
Additional Paid in Capital 289M USD +4739%
Preferred Stock, Shares Outstanding 0 shares
Operating Leases, Future Minimum Payments, Due in Two Years 69K USD
Depreciation, Depletion and Amortization 0 USD -100%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 1.03M USD
Deferred Tax Assets, Net of Valuation Allowance 1.09M USD -43.6%
Share-based Payment Arrangement, Expense 3.49M USD +211%
Operating Leases, Future Minimum Payments, Due in Three Years 0 USD
Operating Leases, Future Minimum Payments Due 1.81M USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares